Should we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort study

Kramer, Tobias SiegfriedSoriano, AlexTedeschi, SarahChen, Antonia F.Tattevin, PierreSenneville, EricGómez Junyent, JoanBirlutiu, VictoriaPetersdorf, SabineDiaz de Brito, VicensSancho González, IgnacioBelden, Katherine A.Wouthuyzen-Bakker, Marjan2024-04-192024-04-192024Kramer TS, Soriano A, Tedeschi S, Chen AF, Tattevin P, Senneville E, et al. Should we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort study. Open Forum Infect Dis. 2024 Feb 8;11(3):ofae075. DOI: 10.1093/ofid/ofae0752328-8957http://hdl.handle.net/10230/59833application/pdfeng© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Microbiologia mèdicaInfeccióShould we use rifampicin in periprosthetic joint infections caused by staphylococci when the implant has been exchanged? A multicenter observational cohort studyinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1093/ofid/ofae075info:eu-repo/semantics/openAccess